PV

Pace Ventures Enigma

Europe, Berlin, Germany, Berlin

Description

Life Science & DeepTech Fund

Investor Profile

Pace Ventures Enigma has made 9 investments, with 5 in the past 12 months and 33% as lead.

Stage Focus

  • Seed (44%)
  • Series Unknown (33%)
  • Series A (11%)
  • Pre Seed (11%)

Country Focus

  • United States (67%)
  • Germany (22%)
  • United Kingdom (11%)

Industry Focus

  • Biotechnology
  • Drone Management
  • Drones
  • Manufacturing
  • Robotics
  • Artificial Intelligence (Ai)
  • Information Technology
  • Health Care
  • Medical
  • Augmented Reality
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pace Ventures Enigma frequently co-invest with?

Capitalia
Europe, Riga, Latvia, Riga
Co-Investments: 1
Future Positive Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 2
N&V Capital
Europe, Vaduz, Liechtenstein, Vaduz
Co-Investments: 1
Springboard Health Angels
Europe, Berlin, Germany, Berlin
Co-Investments: 1
Metaplanet
Europe, Harjumaa, Estonia, Tallinn
Co-Investments: 2
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 1
Change Ventures
Europe, Harjumaa, Estonia, Tallinn
Co-Investments: 2
Accenture Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Honeystone Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
DvH Ventures
Europe, Nordrhein-Westfalen, Germany, Köln
Co-Investments: 1

Which angels does Pace Ventures Enigma often collaborate with?

CG
North America, Utah, United States, Salt Lake City
Shared Deals: 1
JB
North America, California, United States, San Francisco
Shared Deals: 1
JT
Europe, Harjumaa, Estonia, Tallinn
Shared Deals: 1
AW
Europe, Berlin, Germany, Berlin
Shared Deals: 1
Shared Deals: 1
MM
Europe, Lithuania
Shared Deals: 2
AC
Europe, Berlin, Germany, Berlin
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Pace Ventures Enigma?

Vema Hydrogen

Wilmington, Delaware, United States

Vema Hydrogen is a pioneering clean hydrogen production company. It helps to fight the enormous decarbonization issue.

CleanTechEnvironmental Consulting
SeedFeb 18, 2025
Amount Raised: $13,000,000
Dunia Innovation

Berlin, Berlin, Germany

Dunia Innovations is a Breakthrough materials for tomorrow's net zero planet.

Nanotechnology
Series UnknownOct 23, 2024
Amount Raised: $11,500,000
Turnover Labs

New York, New York, United States

Turnover Labs strives to decarbonize the chemical production business.

Carbon CaptureChemicalRecycling
Pre SeedOct 22, 2024
Amount Raised: $1,400,000
Clearly.Earth

London, England, United Kingdom

AI driven SaaS platform for smarter mobility emission management for fleet owners, operators and customers.

Information TechnologyMobileSoftware
SeedAug 13, 2024
Amount Raised: $4,343,788
Neurable

Boston, Massachusetts, United States

Neurable is a neurotechnology company focused on developing AI tools for brain signal translation and brain-computer interface technology.

Artificial Intelligence (AI)Augmented RealityHuman Computer InteractionVirtual Reality
Series UnknownMay 7, 2024
Amount Raised: $13,000,000
Virtonomy

Munich, Bayern, Germany

Virtonomy's advanced digital patients twin solution, powered by AI and multi-physics simulations, is reshaping the medical device industry

BiotechnologyHealth CareMedical
Series UnknownApr 12, 2023
Amount Raised: $3,849,089
Aerones

San Jose, California, United States

Aerones is an innovative company that develops robotic technology for wind turbine blade maintenance services.

Drone ManagementDronesManufacturingRobotics
Series ADec 27, 2022
Amount Raised: $31,909,802
Aerones

San Jose, California, United States

Aerones is an innovative company that develops robotic technology for wind turbine blade maintenance services.

Drone ManagementDronesManufacturingRobotics
SeedApr 28, 2022
Amount Raised: $8,300,000
Celeris Therapeutics

Menlo Park, California, United States

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.

Artificial Intelligence (AI)BiotechnologyInformation TechnologyLife SciencePharmaceutical
SeedFeb 10, 2022
Amount Raised: $3,423,302